10 Biggest Price Target Changes For Tuesday

3/15/22 7:52:24 AM ET

Finance: Consumer Services

Finance

Department/Specialty Retail Stores

Consumer Discretionary

Get the next $AFRM alert in real time by email

Wells Fargo cut the price target on Coupa Software Incorporated (NYSE:LPI) from $190 to $80. Laredo Petroleum shares fell 29.8% to $63.10 in pre-market trading.
Credit Suisse raised HollyFrontier Corporation (NYSE:HFC) price target from $44 to $50. HollyFrontier shares fell 0.2% to $36.33 in pre-market trading.
Raymond James cut the price target on EverCommerce Inc. (NASDAQ:EVCM) from $24 to $17. EverCommerce shares fell 1.6% to $12.02 in pre-market trading.
Barclays boosted the price target for Ulta Beauty, Inc. (NASDAQ:ULTA) from $440 to $469. Ulta Beauty shares rose 0.3% to $358.50 in pre-market trading.
SVB Leerink cut Nektar Therapeutics (NASDAQ:NKTR) price target from $18 to $7. Nektar Therapeutics shares fell 1.2% to $4.11 in pre-market trading.

Check out this: Insiders Buy Around $21M Of 3 Stocks

Check out other big price target changes here

Get the next $AFRM alert in real time by email

Crush Q1 2026 with the Best AI Superconnector

Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

AI-Powered Inbox

Context-aware email replies

Strategic Decision Support

Get Started with Standout.work

Recent Analyst Ratings for
$AFRM
$DG
$EVCM
$EVLV

Company	Date	Price Target	Rating	Analyst
Affirm Holdings Inc. $AFRM	4/22/2026	$75.00	Outperform	BMO Capital Markets
Ulta Beauty Inc. $ULTA	4/20/2026	$700.00	Hold → Buy	Jefferies
Nike Inc. $NKE	4/13/2026	$48.00	Buy → Hold	HSBC Securities
Nike Inc. $NKE	4/10/2026	$50.00	Overweight → Neutral	Piper Sandler
Nike Inc. $NKE	4/1/2026	$52.00	Overweight → Neutral	Analyst
Nike Inc. $NKE	4/1/2026	$52.00	Buy → Neutral	Goldman
Nike Inc. $NKE	4/1/2026	$55.00	Buy → Neutral	BofA Securities
Nike Inc. $NKE	3/25/2026	$72.00 → $65.00	Market Perform	Telsey Advisory Group

More analyst ratings

$AFRM
$DG
$EVCM
$EVLV
Press Releases

Fastest customizable press release news feed in the world

Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced the closing of its underwritten public offering of $373.8 million of shares of its common stock. Nektar sold 4,062,500 shares of common stock in the offering, which includes 529,891 shares sold upon exercise in full by the underwriters of their option to purchase additional shares of common stock in the offering. The shares of common stock were sold at a public offering price of $92.00 per share. The gross proceeds to Nektar from the offering were approximately $373.8 million, before deducting underwritin

4/23/26 4:15:00 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Ulta Beauty and Google Introduce Gemini-Enabled Shopping Experiences That Streamline Beauty Discovery and Purchase

Ulta Beauty launches agentic commerce across Google surfaces and introduces Ulta AI, a new AI shopping assistant built with Gemini Enterprise for Customer Experience LAS VEGAS, April 22, 2026 /PRNewswire/ -- Cloud Next '26 -- Ulta Beauty and Google today announced two new Gemini-enabled innovations designed to make beauty shopping more seamless, personalized and intuitive across digital touchpoints. As beauty discovery increasingly shifts to AI-powered experiences, Ulta Beauty is expanding how guests discover, compare and shop for products—both across Ulta Beauty's own digital p

4/22/26 8:00:00 AM ET

Other Specialty Stores

Consumer Discretionary

Nektar Therapeutics Announces Pricing of Upsized $325 Million Public Offering

SAN FRANCISCO, April 21, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced the pricing of its upsized underwritten public offering of $325 million of shares of its common stock. Nektar is selling 3,532,609 shares of common stock at a public offering price of $92.00 per share. The gross proceeds to Nektar from the offering are expected to be approximately $325 million, before deducting underwriting discounts and commissions and estimated offering expenses. In addition, Nektar has granted the underwriters a 30-day option to purchase up to an additional

4/21/26 9:30:00 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

$AFRM
$DG
$EVCM
$EVLV
Financials

Live finance-specific insights

Nektar to Hold Conference Call to Discuss 52-Week Topline Results from the 16-Week Extension Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on April 20, 2026

SAN FRANCISCO, April 19, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced it will host an investor call and live webcast to review 52-week topline results from the 16-week extension treatment period of the ongoing Phase 2b REZOLVE-AA clinical trial of investigational rezpegaldesleukin, a regulatory T-cell (Treg) proliferator, for severe-to-very-severe alopecia areata on Monday, April 20, 2026 at 8:00 am ET / 5:00 am PT. Conference Call The results will be provided

4/19/26 12:00:00 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

EverCommerce Announces Date of First Quarter 2026 Earnings Call

DENVER, April 17, 2026 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ:EVCM), a leading AI-powered platform helping service SMBs run smarter and grow faster, will report its first quarter 2026 financial results after the U.S. financial markets close on Thursday, May 7, 2026. Management will host a conference call on Thursday, May 7 at 5:00 p.m. Eastern Time / 3:00 p.m. Mountain Time to discuss the Company's financial results and provide a business update. Please visit the "Investor Relations" page of the Company's website (https://investors.evercommerce.com/) for both telephonic and webcast access to this call; a replay will be archived on the website as well. About EverCommerce EverComme

4/17/26 9:00:00 AM ET

Computer Software: Prepackaged Software

Technology

Affirm to announce third quarter fiscal year 2026 results on May 7, 2026

Affirm Holdings, Inc. (NASDAQ:AFRM) today announced it will publish its third quarter fiscal year 2026 shareholder letter, including its financial results, on its investor relations website at https://investors.affirm.com/ on Thursday, May 7, 2026, after market close. The Company will host a conference call and webcast at 2:00pm PT that same day. Hosting the call will be Max Levchin (Founder and Chief Executive Officer), Michael Linford (Chief Operating Officer), and Rob O'Hare (Chief Financial Officer). A replay will be available on the investor relations website following the call. About Affirm Affirm's mission is to deliver honest financial products that improve lives. By building

4/16/26 4:07:00 PM ET

Finance: Consumer Services

Finance

$AFRM
$DG
$EVCM
$EVLV
Leadership Updates

Live Leadership Updates

Dollar General Corporation Appoints Jerry W. "JJ" Fleeman Jr., as Chief Executive Officer

Fleeman to succeed Todd Vasos as CEO effective January 1, 2027 Dollar General Corporation (NYSE:DG) today announced that its Board of Directors has appointed Jerry W. "JJ" Fleeman Jr., to succeed Todd Vasos as Chief Executive Officer (CEO) of Dollar General effective January 1, 2027. The Board intends to appoint Fleeman to serve as a director upon the effective date of the transition. To assist in the transition, Vasos will continue to serve as CEO until the effective date of the transition, at which time he will serve as Senior Advisor through April 2, 2027. Following the transition, Vasos is expected to remain a member of the Board. "On behalf of the Board of Directors, I want to ex

3/24/26 9:00:00 AM ET

Department/Specialty Retail Stores

Consumer Discretionary

Evolv Technology Announces the Appointment of Henrik Kühl as a New Independent Director

– Long-Time Member of the Board of Directors and Early Venture Capitalist Bilal Zuberi Resigns from Board – Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced the appointment of Mr. Henrik Kühl, age 46, to its Board of Directors ("Board") effective February 12, 2026. Kühl will also serve on the Board's Audit Committee. The Board affirmatively determined that Kühl is independent and an audit committee financial expert as that term is defined by applicable Securities and Exchange Commission regulations. Kühl is an accomplished leader with over 25 years of experience in c

2/12/26 8:00:00 AM ET

Ordnance And Accessories

Industrials

Computer peripheral equipment

Technology

TransAct Appoints Dana Loof as Chief Marketing Officer to Accelerate Growth and Platform Expansion

TransAct Technologies Incorporated (NASDAQ:TACT) ("TransAct" or the "Company"), a global leader in software-driven technology and integrated printing solutions, today announced the appointment of Dana Loof as Chief Marketing Officer. Ms. Loof will lead TransAct's global marketing organization, with a mandate to strengthen brand leadership, sharpen go-to-market execution, and accelerate adoption of the Company's growing technology portfolio. Ms. Loof has a 30-year track record leading high-growth technology companies, where she has been responsible for global marketing strategy, brand strategy and positioning, category building, revenue generation, and customer engagement initiatives. In h

1/20/26 4:05:00 PM ET

Computer peripheral equipment

Technology